IP Library Granted Patent US 9,993,559
Granted Patent B2
US 9,993,559 · App. 15/166,409 · Granted Jun 12, 2018

N-alkyl lactam ethers, and compositions and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,993,559
App. No.
15/166,409
Granted
Jun 12, 2018
Kind
B2
Abstract

Described is a class of symmetrical and asymmetrical N-alkyl lactam ethers. One preferred ether is bis-N-ethyl pyrrolidone ether. Preferred compositions and uses of the ethers are in performance chemicals, personal care, and pharmaceutical fields, where they function a variety of roles, including as a solvent, solubilizer, freezing point depressor, diluent, extracting agent, cleaning agent, degreaser, absorbent and/or dispersion agent.

Claims (7)

1. A compound represented by the structure:

wherein:

one of A l and A 2 is —CH 2 CH 2 — and the other is —CH 2 CH 2 CH 2 —;

said Q 1 and Q 2 are independently selected from a linear or branched C 1-6 alkyl; and

each said R is independently selected from the group consisting of hydrogen, and C 1-4 alkyl.

2. The compound according to claim 1 selected from the group consisting of:

3. A sun care composition comprising the compound of claim 1 and one or more UV absorbers selected from the group consisting of: p-aminobenzoic acid (PABA), Padimate O, ensulizole, cinoxate, benzophenone-3, enzophenone-8, homosalate, meradimate, octocrylene, 2-ethylhexyl-p-methoxycinnamate, octyl salicylate, sulisobenzone, trolamine salicylate, avobenzone, ecamsule, titanium dioxide, zinc oxide, 4-methylbenzylidene, Tinosorb M, neo heliopan AP, mexoryl XL, benzophenone-9, Uvinul T150, Uvinul A Plus, Uvasorb HEB, Parsol SLX, isopentenyl-4-methoxycinnamate, and combinations thereof.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →